{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:08:33Z","timestamp":1774397313681,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671335"],"award-info":[{"award-number":["31671335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2016CFB103"],"award-info":[{"award-number":["2016CFB103"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2014A030313726"],"award-info":[{"award-number":["2014A030313726"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2014A030313095"],"award-info":[{"award-number":["2014A030313095"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Medical Research Project of Wuhan Health and Family Planning Commission","award":["WX13A01"],"award-info":[{"award-number":["WX13A01"]}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jcyt.2017.01.008","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T06:18:28Z","timestamp":1487225908000},"page":"617-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models"],"prefix":"10.1016","volume":"19","author":[{"given":"Yi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bicheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenggao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2017.01.008_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: globocan","volume":"94","author":"Parkin","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","article-title":"Estimates of the world-wide prevalence of cancer for 25 sites in the adult population","volume":"97","author":"Pisani","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0020","first-page":"371","article-title":"Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear","volume":"84","author":"Dimberu","year":"2011","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1634\/theoncologist.10-7-528","article-title":"Vaccines against human papillomavirus and cervical cancer: promises and challenges","volume":"10","author":"Ali","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ijc.23252","article-title":"Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions","volume":"122","author":"Kanodia","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"Zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/imr.12132","article-title":"Exploiting the curative potential of adoptive T-cell therapy for cancer","volume":"257","author":"Hinrichs","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2012.00375","article-title":"Biological role of NK cells and immunotherapeutic approaches in breast cancer","volume":"3","author":"Roberti","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0050","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/ijc.28217","article-title":"Human V\u03b32V\u03b42 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors","volume":"133","author":"Aggarwal","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/bbmt.2001.v7.pm11349808","article-title":"Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation","volume":"7","author":"Alvarnas","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1705503","article-title":"A Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation","volume":"38","author":"Introna","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"28","key":"10.1016\/j.jcyt.2017.01.008_bib0065","doi-asserted-by":"crossref","first-page":"43604","DOI":"10.18632\/oncotarget.9871","article-title":"Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0070","first-page":"3493","article-title":"Optimized protocols for generation of cord blood-derived cytokine- induced killer\/natural killer cells","volume":"30","author":"Li","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0075","doi-asserted-by":"crossref","first-page":"e93886","DOI":"10.1371\/journal.pone.0093886","article-title":"Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0080","doi-asserted-by":"crossref","first-page":"649359","DOI":"10.1155\/2011\/649359","article-title":"The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptide","volume":"2011","author":"Tan","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.coi.2011.12.009","article-title":"Targeting the PD-1\/B7-H1 (PD-L1) pathway to activate anti-tumor immunity","volume":"24","author":"Topalian","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fimmu.2013.00469","article-title":"Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells","volume":"4","author":"Larkin","year":"2013","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jcyt.2017.01.008_bib0095","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.4161\/hv.29754","article-title":"Engineering better immunotherapies via RNA interference","volume":"10","author":"Sioud","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0100","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni1012","article-title":"Suppressors of cytokine signaling and immunity","volume":"4","author":"Kubo","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response","volume":"22","author":"Alexander","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0110","doi-asserted-by":"crossref","first-page":"943149","DOI":"10.1155\/2014\/943149","article-title":"SOCS1 and regulation of regulatory T cells plasticity","volume":"2014","author":"Takahashi","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0115","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1349-7006.2009.01098.x","article-title":"Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation","volume":"100","author":"Hashimoto","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0120","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1128\/CVI.00130-13","article-title":"A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen- specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells","volume":"20","author":"Wang","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1074-7613(03)00240-1","article-title":"Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity","volume":"19","author":"Hanada","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00262-011-1034-2","article-title":"Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4+and CD8+T cells","volume":"60","author":"Guenterberg","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0135","doi-asserted-by":"crossref","first-page":"26873","DOI":"10.1074\/jbc.M111.238287","article-title":"Silencing suppressor of cytokine signaling-1(SOCS1) in macrophages improves mycobacterium tuberculosis control in an IFN-\u03b3-dependent","volume":"286","author":"Carow","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0140","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.4049\/jimmunol.1003819","article-title":"Inhibition of SOCS1\/lethal autoinflammatory disease correlated to enhanced peripheral Foxp3+ regulatory T cell homeostasis","volume":"187","author":"Collins","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0145","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1084\/jem.20110428","article-title":"SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-\u03b3 and IL-17A production","volume":"208","author":"Takahashi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0150","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ijo.2013.2027","article-title":"Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus","volume":"43","author":"Zhu","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0155","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/nbt1035","article-title":"Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity","volume":"22","author":"Shen","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0160","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00262-010-0860-y","article-title":"IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy","volume":"59","author":"Helms","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0165","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.3390\/ijms150814632","article-title":"Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies","volume":"15","author":"Schmeel","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12967-014-0215-0","article-title":"Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors","volume":"12","author":"Li","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0175","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1517\/14712598.2014.900537","article-title":"An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells","volume":"14","author":"J\u00e4kel","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0180","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/1078-0432.CCR-14-0082","article-title":"Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer","volume":"20","author":"Pan","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0185","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3748\/wjg.v20.i4.1095","article-title":"Combination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis","volume":"20","author":"Wang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0190","doi-asserted-by":"crossref","first-page":"e108958","DOI":"10.1371\/journal.pone.0108958","article-title":"Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis","volume":"9","author":"Han","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0195","doi-asserted-by":"crossref","first-page":"e93591","DOI":"10.1371\/journal.pone.0093591","article-title":"Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells","volume":"9","author":"Pan","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.jcyt.2017.01.008_bib0200","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1182\/blood-2011-02-336321","article-title":"Dual-functional capability of CD3+CD56+CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity","volume":"118","author":"Pievani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0205","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood.V97.10.2923","article-title":"Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production","volume":"97","author":"Baker","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0210","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2003-06-2125","article-title":"Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells","volume":"103","author":"Verneris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0215","doi-asserted-by":"crossref","first-page":"e102197","DOI":"10.1371\/journal.pone.0102197","article-title":"Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0220","doi-asserted-by":"crossref","first-page":"35023","DOI":"10.18632\/oncotarget.5280","article-title":"Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition","volume":"6","author":"Wei","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2017.01.008_bib0225","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.vaccine.2007.11.020","article-title":"SOCS1 downregulation in dendritic cells promotes memory T-cell responses","volume":"26","author":"Aldrich","year":"2008","journal-title":"Vaccine"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917300348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917300348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:24:11Z","timestamp":1761431051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324917300348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1465324917300348"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.01.008","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}